These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13677136)

  • 1. [Prophylaxis of candidosis in case of secondary immunodeficiency].
    Kolbin AS; Ivanov DO; Shabalov NP; Klimko NN; Karpov OI
    Antibiot Khimioter; 2003; 48(4):35-9. PubMed ID: 13677136
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
    Long SS; Stevenson DK
    J Pediatr; 2005 Aug; 147(2):135-41. PubMed ID: 16126036
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
    Patel R
    Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
    [No Abstract]   [Full Text] [Related]  

  • 4. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Lee DH
    Ann Intern Med; 2009 Jan; 150(1):59; author reply 59-60. PubMed ID: 19124827
    [No Abstract]   [Full Text] [Related]  

  • 5. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Shelburne SA
    Ann Intern Med; 2009 Jan; 150(1):58-9; author reply 59-60. PubMed ID: 19124825
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
    Kaufman DA
    Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole prophylaxis.
    Ho KM
    Crit Care Med; 2006 Feb; 34(2):584-5; author reply 585-6. PubMed ID: 16424775
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
    Kaufman DA; Morris A; Gurka MJ; Kapik B; Hetherington S
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S87-90. PubMed ID: 24709470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is routine fluconazole prophylaxis necessary in preterm infants?
    Morales-Molina JA; Mateu-de Antonio J; Grau S; Luque S; Berenguer N
    Pharm World Sci; 2006 Jun; 28(3):163-4. PubMed ID: 17004020
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluconazole prophylaxis in the neonatal intensive care unit.
    Healy CM; Baker CJ
    Pediatr Infect Dis J; 2009 Jan; 28(1):49-52. PubMed ID: 19106754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Candidosis].
    Takakura S
    Med Mycol J; 2011; 52(1):15-8. PubMed ID: 21441708
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
    Vendettuoli V; Vento G; Tirone C; Posteraro B; Romagnoli C
    Pediatrics; 2009 Feb; 123(2):e368-9. PubMed ID: 19171602
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis for intensive care unit patients: let's fine tune it.
    Calandra T; Marchetti O
    Intensive Care Med; 2002 Dec; 28(12):1698-1700. PubMed ID: 12580153
    [No Abstract]   [Full Text] [Related]  

  • 16. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies for the prevention of neonatal candidiasis.
    Leibovitz E
    Pediatr Neonatol; 2012 Apr; 53(2):83-9. PubMed ID: 22503254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.